Alanine prevents the decrease of Na+,K+-ATPase activity in experimental phenylketonuria.

This publication has 21 references indexed in Scilit:

• Anabolic Effect of Human Growth Hormone: Management of Inherited Disorders of Catabolic Pathways
  Biochemical Medicine and Metabolic Biology, 1994
• On the mechanism of permanent brain dysfunction in hyperphenylalaninemia
  Biochemical Medicine and Metabolic Biology, 1991
• An occipito‐temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia
  Journal of Inherited Metabolic Disease, 1991
• Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology
  Brain Research Reviews, 1991
• Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging
  European Journal of Pediatrics, 1991
• Neurological deterioration in young adults with phenylketonuria
  The Lancet, 1990
• Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.
  Journal of Clinical Investigation, 1985
• Glial and neuronal Na+-K+ pump in epilepsy
  Annals of Neurology, 1984
• A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
  Analytical Biochemistry, 1976
• Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1974